Biochemical Engineering Special Interest Group
biological engineering professionals
26 January 2017

Biocon bags Rs460-crore contract from Malaysia

Biotechnology major Biocon has bagged a MYR 300-million (about Rs 460.5 crore) contract from the Ministry of Health, Malaysia, to supply recombinant human insulin formulations for a period of three years. The drug, manufactured by Biocon at its large scale biopharmaceutical facility in Johor, Malaysia, is the country's first locally manufactured biosimilar biologic product, Biocon said in a BSE filing today. Source: Economic Times 26/1/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).